Letrozole 2.5mg – 28 Tablets

Letrozole in Cancer Treatment

Letrozole emerges as a pivotal player in the realm of breast cancer treatment, showcasing its efficacy in both advanced and early-stage diseases. With its multifaceted indications and therapeutic benefits, Letrozole stands as a beacon of hope for individuals battling breast cancer, offering enhanced treatment options and improved quality of life.

• Anti-Cancer Agent: Letrozole is classified as an aromatase inhibitor, belonging to the group of anti-cancer drugs, with its primary ingredient being Letrozole.
• Immunomodulatory Effects: Letrozole impacts the immune system while exerting inhibitory effects on estrogen biosynthesis, making it a multifaceted therapeutic option.

Key Features

• Active Ingredient: Letrozole serves as the main component, driving its anti-cancer properties.
• Formulation: Available as 2.5mg film-coated tablets for ease of administration.

Indications for Use

• Advanced Breast Cancer: Letrozole is indicated for the treatment of advanced breast cancer in postmenopausal women who have previously failed estrogen or tamoxifen therapy.
• Early Invasive Breast Cancer: Utilized in the treatment of early invasive breast cancer in postmenopausal women who have previously received tamoxifen therapy.
• Preoperative Treatment: Prescribed to preserve the nipple in postmenopausal women with hormone receptor-positive breast cancer as part of preoperative therapy.

Treatment Advancements

• Therapeutic Efficacy: Letrozole demonstrates efficacy in managing both advanced and early-stage breast cancer, offering hope and improved outcomes for affected individuals.
• Nipple Preservation: Its role in preoperative therapy contributes to preserving the nipple in women undergoing breast cancer treatment, enhancing cosmetic outcomes.